There's not much news flow with Konekt. The next update (barring...

There's not much news flow with Konekt. The next update (barring more acquisitions) will be the annual report in two months. I'm expecting 3c EPS, maybe 3.5c, and revenue around $43m (and, if adjusted for the acquisitions, pushing towards $50m next year). And I'm hoping for confirmation that all the acquisitions are bedding down ok. Possibly a small dividend if there are franking credits and no further acquisitions planned in the near future.

Given that, and the FY17 growth already built-in from the acquisitions, I don't see that a trailing PE ratio of 20x and a market cap of $50m would be at all unreasonable (consider some of Konekt's peers in health services, admittedly most of them much larger). I think a takeover would have to pay over $50m, given how tightly held the shares are (and keeping in mind there's no debt).

In the longer term... instead of a takeover, how about inclusion in the ASX300 in five years?